Total planned funding: $897,705,158
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $200,929,042 |
| Kenya | $194,400,000 |
| Uganda | $77,863,542 |
| South Africa | $72,989,627 |
| Ethiopia | $69,497,001 |
| Zambia | $54,076,913 |
| Tanzania | $52,109,095 |
| Côte d'Ivoire | $44,794,163 |
| Mozambique | $34,681,930 |
| Rwanda | $21,110,593 |
| Botswana | $17,897,500 |
| Vietnam | $14,130,000 |
| Zimbabwe | $11,288,889 |
| Caribbean Region | $9,364,409 |
| Namibia | $8,145,501 |
| Haiti | $7,462,679 |
| Guyana | $4,470,696 |
| Malawi | $1,300,000 |
| Eswatini | $840,000 |
| Lesotho | $176,578 |
| China | $100,000 |
| South Sudan | $77,000 |
Organizational Types
| Private Contractor | $388,351,331 |
| Unknown | $203,860,526 |
| NGO | $115,254,500 |
| University | $74,691,624 |
| FBO | $64,741,907 |
| Host Country Government Agency | $32,810,627 |
| Implementing Agency | $9,827,995 |
| Own Agency | $4,089,740 |
| Parastatal | $2,294,133 |
| Other USG Agency | $1,782,775 |
Program Areas
| Treatment | $897,705,158 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $897,705,158 |